Using Digital Maps to Predict the Success of Immunotherapy in Cancer Patients
Summary Researchers at Johns Hopkins are developing a new method called ImmunoMap, a digital map that compares different types of T-cell receptors, the “antennas” found on the surface of T-cells that identify foreign substances in the body to trigger an immune response. ImmunoMap will eventually help physicians to predict which cancer patients will respond […]
Continue readingImmunotherapy Innovation Involving Checkpoint Inhibitors Gaining Momentum
A new innovation has shown great success in treating different kinds of tumors in mice that do not react to cancer immunotherapy medications, and they are called checkpoint inhibitors. Y-traps aim at the same proteins as existing checkpoint inhibitors: cytotoxic T-lymphocyte antigen-4 (CTLA-4) and programmed death-1 (PD-1)/PD-1 ligand (PD-L1). These proteins are known to assist […]
Continue reading